Items where Author is "Fleck, Suzanne L"
Number of items: 28.
2022
  • Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols. (2022) Baiden, Frank; Fleck, Suzanne; Leigh, Bailah; Ayieko, Philip; Tindanbil, Daniel; Otieno, Tuda; Lawal, Bolarinde; Tehtor, Mattu; Rogers, Maariam; Odeny, Lazarus; Hodges, Mary H; Sonnie, Mustapha; Samai, Mohamed; Ishola, David; Lowe, Brett; Watson-Jones, Deborah; Greenwood, Brian
  • 2019
  • The Safety and Immunogenicity of GTU®MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART. (2019) Haidari, G; Day, Suzanne; Wood, M; Ridgers, H; Cope, Alethea V; Fleck, Sue; Yan, Celine; Reijonen, Kalevi; Hannaman, Drew; Spentzou, Aggeliki; Hayes, Peter; Vogt, A; Combadiere, Behazine; Cook, Adrian; McCormack, Sheena; Shattock, Robin J
  • 2018
  • Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine. (2018) Cheeseman, Hannah Mary; Day, Suzanne; McFarlane, Leon Robert; Fleck, Sue; Miller, Aleisha; Cole, Tom; Sousa-Santos, Nelson; Cope, Alethea; Cizmeci, Deniz; Tolazzi, Monica; Hwekwete, Edith; Hannaman, Drew; Kratochvil, Sven; McKay, Paul Francis; Chung, Amy W; Kent, Stephen J; Cook, Adrian; Scarlatti, Gabriella; Abraham, Sonya; Combadiere, Behazine; McCormack, Sheena; Lewis, David John; Shattock, Robin John
  • Optimizing the immunogenicity of HIV prime-boost DNA-MVA-rgp140/GLA vaccines in a phase II randomized factorial trial design. (2018) Viegas, Edna O; Kroidl, Arne; Munseri, Patricia J; Missanga, Marco; Nilsson, Charlotta; Tembe, Nelson; Bauer, Asli; Joachim, Agricola; Joseph, Sarah; Mann, Philipp; Geldmacher, Christof; Fleck, Sue; Stöhr, Wolfgang; Scarlatti, Gabriella; Aboud, Said; Bakari, Muhammad; Maboko, Leonard; Hoelscher, Michael; Wahren, Britta; Robb, Merlin L; Weber, Jonathan; McCormack, Sheena; Biberfeld, Gunnel; Jani, Ilesh V; Sandström, Eric; Lyamuya, Eligius; TaMoVac study group
  • 2014
  • Neurocognitive function in HIV-infected patients: comparison of two methods to define impairment. (2014) Arenas-Pinto, Alejandro; Winston, Alan; Stöhr, Wolfgang; Day, John; Wiggins, Rebecca; Quah, Say Pheng; Ainsworth, Jonathan; Fleck, Sue; Dunn, David; Accoroni, Alex; Paton, Nicholas I; PIVOT Trial Team
  • 2009
  • Heterogeneity in patterns of malarial oocyst infections in the mosquito vector. (2009) Medley, GF; Sinden, RE; Fleck, S; Billingsley, PF; Tirawanchap, N; Rodriguez, MH
  • Characterization of the modes of action of anti-Pbs21 malaria transmission-blocking immunity: ookinete to oocyst differentiation in vivo. (2009) Ranawaka, GRR; Fleck, SL; Alejo Blanco, AR; Sinden, RE
  • 2003
  • Suramin and suramin analogues inhibit merozoite surface protein-1 secondary processing and erythrocyte invasion by the malaria parasite Plasmodium falciparum. (2003) Fleck, Suzanne L; Birdsall, Berry; Babon, Jeffrey; Dluzewski, Anton R; Martin, Stephen R; Morgan, William D; Angov, Evelina; Kettleborough, Catherine A; Feeney, James; Blackman, Michael J; Holder, Anthony A
  • A single malaria merozoite serine protease mediates shedding of multiple surface proteins by juxtamembrane cleavage. (2003) Howell, Steven A; Well, Isabelle; Fleck, Suzanne L; Kettleborough, Catherine; Collins, Christine R; Blackman, Michael J
  • 2002
  • The chemotherapy of rodent malaria. LX. The importance of formulation in evaluating the blood schizontocidal activity of some endoperoxide antimalarials. (2002) Peters, W; Fleck, SL; Robinson, BL; Stewart, LB; Jefford, CW
  • 1999
  • Antigenic and sequence diversity at the C-terminus of the merozoite surface protein-1 from rodent malaria isolates, and the binding of protective monoclonal antibodies. (1999) Benjamin, PA; Ling, IT; Clottey, G; Spencer Valero, LM; Ogun, SA; Fleck, SL; Walliker, D; Morgan, WD; Birdsall, B; Feeney, J; Holder, AA
  • 1997
  • The chemotherapy of rodent malaria. LIV. Combinations of 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane, with other drugs against drug-sensitive and drug-resistant parasites. (1997) Fleck, SL; Robinson, BL; Peters, W
  • The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series. (1997) Fleck, SL; Robinson, BL; Peters, W; Thévin, F; Boulard, Y; Glénat, C; Caillard, V; Landau, I
  • 1996
  • The effect of atovaquone (566C80) on the maturation and viability of Plasmodium falciparum gametocytes in vitro. (1996) Fleck, SL; Pudney, M; Sinden, RE
  • Regulation of Infectivity of Plasmodium to the Mosquito Vector. (1996) Sinden, RE; Butcher, GA; Billker, O; Fleck, SL
  • 1995
  • Specific and nonspecific responses to Plasmodium falciparum blood-stage parasites and observations on the gametocytemia in schoolchildren living in a malaria-endemic area of Mozambique. (1995) Hogh, B; Thompson, R; Hetzel, C; Fleck, SL; Kruse, N; Jones, I; Dgedge, MDC; Barreto, J; Sinden, RE
  • 1994
  • Plasmodium berghei: Serum-Mediated Inhibition of Infectivity of Infected Mice to Anopheles stephensi Mosquitos. (1994) Fleck, SL; Butcher, GA; Sinden, RE
  • 1993
  • The SCID Mouse as a Laboratory Model for Development of the Exoerythrocytic Stages of Human and Rodent Malaria. (1993) Butcher, GA; Couchman, AF; Vanpelt, JF; Fleck, SL; Sinden, RE
  • The SCID Mouse as a Laboratory Model for Development of the Exoerythrocytic Stages of Human and Rodent Malaria. (1993) Butcher, GA; Couchman, AF; Vanpelt, JF; Fleck, SL; Sinden, RE
  • Factors regulating natural transmission of Plasmodium berghei to the mosquito vector, and the cloning of a transmission-blocking immunogen. (1993) Sinden, RE; Barker, GC; Patón, M; Fleck, SL; Butcher, GA; Waters, AP; Janse, CJ; Rodriguez, MH
  • Immunological Detection of Cytoskeletal Proteins In the Exoerythrocytic Stages of Malaria By Fluorescence and Confocal Laser Scanning Microscopy. (1993) Suhrbier, A; Sinden, RE; Couchman, A; Fleck, SL; Kumar, S; McMillan, D
  • 1991
  • The antimalarial activity of mouse tumour necrosis serum is blocked by purines. (1991) Butcher, GA; Carr, RE; Fleck, SL
  • Plasmodium berghei: Ionic regulation and the induction of gametogenesis. (1991) Kawamoto, F; Alejo-Blanco, R; Fleck, SL; Sinden, RE
  • 1990
  • Possible roles of Ca2+ and cGMP as mediators of the exflagellation of Plasmodium berghei and Plasmodium falciparum. (1990) Kawamoto, F; Alejo-Blanco, R; Fleck, SL; Kawamoto, Y; Sinden, RE
  • 1987
  • The complete development in vitro of the vertebrate phase of the mammalian malarial parasite Plasmodium berghei. (1987) Suhrbier, A; Janse, C; Mons, B; Fleck, SL; Nicholas, J; Davies, CS; Sinden, RE
  • 1986
  • The recognition of Schistosoma mansoni surface antigens by antibodies from patients infected with S. mansoni and S. haematobium. (1986) Simpson, AJG; Hackett, F; Kelly, C; Knight, M; Payares, G; Omer-Ali, P; Lillywhite, J; Fleck, SL; Smithers, SR
  • 1985
  • Detection of Giardia in human jejunum by the immunoperoxidase method. Specific and non-specific results. (1985) McGregor, I; Fleck, SL; Hames, SE; Warhurst, DC
  • Versatile Field's stain. (1985) Moody, AH; Fleck, SL